Pharmaceuticals

Retinal Disorder Treatment Market Growth Patterns And Forecast Outlook Through 2030

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Retinal Disorder Treatment Market Projected To Reach By 2030?

The market size for retinal disorder treatment has demonstrated significant growth in recent years. It is anticipated to expand from $13.69 billion in 2025 to $14.86 billion in 2026, registering a compound annual growth rate (CAGR) of 8.6%. The historical increase in this market can be linked to the rising prevalence of age-related macular degeneration, the growing global diabetic population, the expansion of ophthalmology clinics and specialized hospitals, advancements in retinal imaging technologies, and increased awareness of retinal diseases.

The market for retinal disorder treatments is projected to experience substantial expansion in the coming years. This market is set to reach $21.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth is driven by several factors, including the development of long-acting retinal medications, the increasing approval of innovative biologics and gene therapies, the expansion of eye care access in developing economies, increased investment in ophthalmic research, and a rising demand for customized retinal treatments. Key trends anticipated during the forecast period involve the increasing adoption of anti-VEGF treatments, a move towards less invasive retinal procedures, a growing preference for sustained-release drug formulations, the broadening of combination therapy strategies, and the greater utilization of home-based vision monitoring devices.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12701&type=smp

Which Drivers Are Supporting The Retinal Disorder Treatment Market Growth?

A rise in diabetes cases is projected to stimulate the expansion of the retinal disorder treatment market moving ahead. This chronic medical condition, diabetes, is defined by heightened blood glucose (blood sugar) levels, which occur when the body either fails to produce sufficient insulin or cannot use the insulin it makes efficiently. Among individuals with diabetes, diabetic retinopathy stands as the most prevalent retinal disorder. This condition results from damage to retinal blood vessels, potentially leading to hemorrhaging, fluid escape, and the proliferation of new blood vessels. Treatment for retinal disorders involves the use of lasers to seal off leaking blood vessels or eliminate abnormal ones. As an illustration, data from June 2024 by the National Health Service, a UK-based government department, indicated that in 2023, the NHS discovered more than half a million (549,000) new individuals in England facing a risk of type 2 diabetes, elevating the total count of those with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marked a substantial rise when contrasted with the 3,065,825 recorded in 2022. Consequently, the expanding occurrence of diabetes is propelling the growth within the retinal disorder treatment market.

Which Segment Classifications Are Used In The Retinal Disorder Treatment Market Segment Analysis?

The retinal disorder treatment market covered in this report is segmented –

1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types

2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration

2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy

3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders

Which Trends Are Guiding The Direction Of The Retinal Disorder Treatment Market?

Leading companies in the retinal disorder treatment market are actively developing innovative products, such as geographic atrophy treatments, with the goal of reaching broader customer bases, increasing sales, and boosting revenue. Available treatment options for geographic atrophy primarily focus on managing symptoms, slowing the disease’s progression, and assisting individuals in coping with visual impairment. For instance, in August 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, announced U.S. Food and Drug Administration (FDA) approval for IZERVAY. IZERVAY, functioning as a novel complement C5 inhibitor, distinguishes itself as the sole approved treatment for geographic atrophy (GA) that has demonstrated a statistically significant reduction (p<0.01) in the rate of GA progression at the 12-month primary endpoint in two Phase 3 clinical trials. This distinctive attribute firmly establishes IZERVAY (avacincaptad pegol intravitreal solution) as an indicated and effective therapy for GA secondary to age-related macular degeneration (AMD).

Which Firms Are Contributing To The Retinal Disorder Treatment Market Ecosystem?

Major companies operating in the retinal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Clearside Biomedical Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV

Get The Full Retinal Disorder Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Which Region Leads The Retinal Disorder Treatment Market In Overall Market Size?

North America was the largest region in the retinal disorder treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Retinal Disorder Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Browse Through More Reports Similar to the Global Retinal Disorder Treatment Market 2026, By The Business Research Company

Retinal Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Optic Nerve Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Retinal Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795